Correlation Between Geron and NRX Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Geron and NRX Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Geron and NRX Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Geron and NRX Pharmaceuticals, you can compare the effects of market volatilities on Geron and NRX Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Geron with a short position of NRX Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Geron and NRX Pharmaceuticals.

Diversification Opportunities for Geron and NRX Pharmaceuticals

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Geron and NRX is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Geron and NRX Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRX Pharmaceuticals and Geron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Geron are associated (or correlated) with NRX Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRX Pharmaceuticals has no effect on the direction of Geron i.e., Geron and NRX Pharmaceuticals go up and down completely randomly.

Pair Corralation between Geron and NRX Pharmaceuticals

Given the investment horizon of 90 days Geron is expected to under-perform the NRX Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Geron is 5.17 times less risky than NRX Pharmaceuticals. The stock trades about -0.22 of its potential returns per unit of risk. The NRX Pharmaceuticals is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  139.00  in NRX Pharmaceuticals on November 1, 2024 and sell it today you would earn a total of  160.00  from holding NRX Pharmaceuticals or generate 115.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Geron  vs.  NRX Pharmaceuticals

 Performance 
       Timeline  
Geron 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Geron has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
NRX Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in NRX Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, NRX Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Geron and NRX Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Geron and NRX Pharmaceuticals

The main advantage of trading using opposite Geron and NRX Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Geron position performs unexpectedly, NRX Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will offset losses from the drop in NRX Pharmaceuticals' long position.
The idea behind Geron and NRX Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing